NCT05737745

Brief Summary

The goal of this clinical trial is to compare physical activity outcomes between endometrial cancer survivors randomized to 1 of 3 conditions: 1) usual care, 2) FitEx, 3) FitEx+yoga. Survivors randomized to FitEx groups will recruit \~3 support team members to complete the intervention with them. The main question\[s\] it aims to answer are:

  • Do FitEx groups undertake more physical activity than the usual care group?
  • Are there differences in quality of life, self-compassion, flourishing, self-efficacy, social support, habit formation, and fruit /vegetable consumption Participants will:
  • Wear a Fitbit
  • Complete surveys
  • Participate in 30 minute weekly virtual meetings (FitEx groups only)
  • Receive weekly newsletters (FitEx groups only)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
111

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 1, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

February 1, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

February 21, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2024

Completed
11 months until next milestone

Results Posted

Study results publicly available

May 9, 2025

Completed
Last Updated

May 9, 2025

Status Verified

April 1, 2025

Enrollment Period

10 months

First QC Date

February 1, 2023

Results QC Date

November 22, 2024

Last Update Submit

April 23, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Moderate to Vigorous Physical Activity of Endometrial Cancer Survivors

    Among survivors, compare changes in objective moderate-vigorous physical activity (MVPA) obtained from FitBits (continuous tracking) between intervention groups and usual care (FitEx-ECS vs. control and FitEx-ECS+yoga vs. control)

    Change from baseline to 8 weeks (post-intervention)

Secondary Outcomes (17)

  • Quality of Life- Survivors

    Change from baseline to 8 weeks (post-intervention)

  • Quality of Life Maintenance- Survivors

    Change from 8 weeks to 6 months (post-intervention)

  • Servings of Daily Fruits and Vegetables Maintenance- Survivors

    Change from 8 weeks to 6 months (post-intervention)

  • Servings of Daily Fruits and Vegetables- Survivors

    Change from baseline to 8 weeks (post-intervention)

  • Flourishing- Survivors

    Change from baseline to 8 weeks (post-intervention)

  • +12 more secondary outcomes

Other Outcomes (15)

  • Moderate to Vigorous Physical Activity- Support Team Members

    Change from baseline to 8 weeks (post-intervention)

  • Moderate to Vigorous Physical Activity Maintenance- Support Team Members

    Change from 8 weeks to 6 months (post-intervention)

  • Flourishing- Support Team Members

    Change from baseline to 8 weeks (post-intervention)

  • +12 more other outcomes

Study Arms (3)

Usual care

NO INTERVENTION

Endometrial cancer survivors will receive standard survivorship care including a one-time educational newsletter about survivorship physical activity and nutrition recommendations. Fitbits will be given to track physical activity.

FitEx-ECS

EXPERIMENTAL

Endometrial cancer survivors and their support team members (as a group of one survivor and their team) will complete the FitEx-ECS intervention program, with a focus on walking. Fitbits will be given to track physical activity.

Behavioral: Self-monitoringBehavioral: Group-dynamicsBehavioral: Weekly virtual sessions- StandardBehavioral: Newsletters- Standard

FitEx-ECS+ Yoga

EXPERIMENTAL

Endometrial cancer survivors and their support team members (as a group of one survivor and their team) will complete the FitEx-ECS+yoga intervention program, with a focus on postures, breathwork, and mindfulness. Fitbits will be given to track physical activity.

Behavioral: Self-monitoringBehavioral: Group-dynamicsBehavioral: Newsletters- YogaBehavioral: Weekly virtual sessions- Yoga

Interventions

Self-monitoringBEHAVIORAL

Tracking physical activity and fruit/vegetable intake.

FitEx-ECSFitEx-ECS+ Yoga
Group-dynamicsBEHAVIORAL

Survivors act as team captains, facilitating interactions between themselves and their support team members and providing goal directed feedback.

FitEx-ECSFitEx-ECS+ Yoga

Weekly 30 minute virtual sessions include support group/team building sessions and 15 minutes of physical activity.

FitEx-ECS

Weekly newsletters support attainment of physical activity and nutrition goals.

FitEx-ECS

Weekly newsletters support attainment of physical activity and nutrition goals, while including mindfulness principles.

FitEx-ECS+ Yoga

Weekly 30 minute virtual sessions include support group/team building sessions and 15 minutes of yoga.

FitEx-ECS+ Yoga

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • SURIVIVOR
  • Diagnosed with early stage (I-II) endometrial cancer, any histology
  • Received cancer care at Carilion Clinic after 1/1/2010
  • At least 18 years of age
  • Have adequate comprehension (reading and writing) of the English language
  • Have a BMI ≥ 30 kg/m\^2 at screening
  • Have stable internet access or access to a smartphone with internet capabilities
  • Meet the requirements of the Physical Activity Readiness Questionnaire(PARQ)
  • Have the capacity to provide informed consent and are willing to provide informed consent
  • SUPPORT TEAM--
  • Were identified by a participant with endometrial cancer as a member of their support system
  • Are at least 18 years of age
  • Have adequate comprehension (reading and writing) of the English language
  • Have stable internet access or access to a smartphone with internet capabilities
  • Meet the requirements of the Physical Activity Readiness Questionnaire (PARQ)
  • +1 more criteria

You may not qualify if:

  • SURVIVOR
  • Recurrent endometrial cancer
  • Meeting physical activity guidelines set forth by the American Cancer Society at screening (greater than 150 minutes/week of moderate physical activity, or greater than 75 minutes/week of vigorous physical activity)
  • SUPPORT TEAM: Have functional limitations requiring a walker, wheelchair, scooter, or other walking aid which limits their capacity to engage in the intervention safely

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Carilion Clinic

Roanoke, Virginia, 24016, United States

Location

MeSH Terms

Conditions

Endometrial NeoplasmsObesitySedentary Behavior

Interventions

Blood Glucose Self-Monitoring

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Blood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, EndocrineMonitoring, PhysiologicSelf-TestingSelf CareTherapeuticsInvestigative Techniques

Limitations and Caveats

Following randomization, 7 participants withdrew from participation due to changes in their ability to attend weekly meetings.

Results Point of Contact

Title
Shannon Armbruster MD, MPH
Organization
Virginia Tech Carilion Clinic

Study Officials

  • Shannon Armbruster, MD MPH

    Carilion Clinic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 1, 2023

First Posted

February 21, 2023

Study Start

February 1, 2023

Primary Completion

November 30, 2023

Study Completion

June 20, 2024

Last Updated

May 9, 2025

Results First Posted

May 9, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations